Adherence to GERD treatment, including medication, diet, and lifestyle, is essential for symptom control and complication prevention, yet adherence rates remain low due to various demographic and clinical factors. Digital therapeutics, particularly mobile health applications, have shown promising potential in supporting chronic disease management and improving patient outcomes. The GERDCare mobile application was developed with direct input from gastrointestinal experts. It is designed to enhance treatment adherence and patient engagement by offering features such as educational resources, symptom tracking, medication reminders, and direct communication between patients and physicians. We are conducting a single-center, open-label, randomized controlled trial to evaluate the effectiveness of using GERDCare in improving patient adherence. Patients are followed up after four weeks of GERD treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
380
Features of GERDCare that support management of GERD
Institute of Gastroenterology and Hepatology
Hanoi, Vietnam
Proportion of patients with good adherence at 4 weeks
Patients achieved a score of ≥27 points on the General Medication Adherence Scale (GMAS)
Time frame: 4 weeks after recruitment
Changes in GERD symptom severity
GERD symptom severity evaluated by the GerdQ score
Time frame: 4 weeks after recruitment
Proportion of patients with clinical improvement after 4 weeks
Symptom resolution evaluated clinically
Time frame: 4 weeks after recruitment
Changes of patients' quality of life after 4 weeks
Patient's quality of life evaluated by the GERD-QoL score
Time frame: 4 weeks after recruitment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.